RETROSPECTIVE COMPARISON OF REAL-LIFE SURVIVAL DATA FROM SINGLE CENTRE TRIALS - THE CLINICAL OUTCOME OF VEMURAFENIB THERAPY IN METASTATIC MELANOMA PATIENTS

被引：0
|
作者：
Porneczy, E. [1 ]
Czirbesz, K. [1 ]
Toth, E. [1 ]
Liszkay, G. [1 ]
Boncz, I [2 ]
机构：
[1] Natl Inst Oncol, Budapest, Hungary
[2] Univ Pecs, Pecs, Hungary
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1082
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN67
引用
收藏
页码：A441 / A441
页数：1
相关论文
共 50 条
  • [1] Efficacy of Vemurafenib Treatment in 43 Metastatic Melanoma Patients with BRAF Mutation. Single-Institute Retrospective Analysis, Early Real-Life Survival Data
    Czirbesz, Kata
    Gorka, Eszter
    Balatoni, Timea
    Panczel, Gitta
    Melegh, Krisztina
    Kovacs, Peter
    Gezsi, Andras
    Liszkay, Gabriella
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (01) : 45 - 50
  • [2] From clinical trials to clinical practice: Real-life outcome data of everolimus and exemestane in the treatment of patients with metastatic breast cancer
    Abdel-Razeq, Hikmat
    Sharaf, Baha'
    Abdulelah, Hazem
    Inserat, Bayan
    Al-Tell, Abdallah
    Salam, Mourad
    Bater, Rayan
    CANCER RESEARCH, 2021, 81 (04)
  • [3] Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study
    Tomsitz, Dirk
    Ruf, Theresa
    Heppt, Markus
    Staeger, Ramon
    Ramelyte, Egle
    Dummer, Reinhard
    Garzarolli, Marlene
    Meier, Friedegund
    Meier, Eileen
    Richly, Heike
    Gromke, Tanja
    Siveke, Jens T.
    Franklin, Cindy
    Klespe, Kai-Christian
    Mauch, Cornelia
    Kilian, Teresa
    Seegraeber, Marlene
    Schilling, Bastian
    French, Lars E.
    Berking, Carola
    Heinzerling, Lucie
    CANCERS, 2023, 15 (13)
  • [4] Long-term tolerability of the BRAF inhibitor vemurafenib in patients with metastatic melanoma: Current study data and real-life observations
    Balmelli C.
    Mark M.
    Spirig C.
    Spataro V.
    Pederiva S.
    Monnerat C.
    Zippelius A.
    Wicki A.
    memo - Magazine of European Medical Oncology, 2014, 7 (3) : 181 - 186
  • [5] Efficacy of vemurafenib treatment in 43 metastatic melanoma patient with BRAF mutation. Single-institute retrospective analysis, early real-life survival data with 15.9 months follow up time
    Czirbesz, K.
    Gorka, E.
    Panczel, G.
    Melegh, K.
    Kovacs, P.
    Gezsi, A.
    Liszkay, G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 61 - 61
  • [6] Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience
    Asher, Nethanel
    Israeli-Weller, Noa
    Shapira-Frommer, Ronnie
    Ben-Betzalel, Guy
    Schachter, Jacob
    Meirson, Tomer
    Markel, Gal
    CANCERS, 2021, 13 (12)
  • [7] Belantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences
    More, Sonia
    Offidani, Massimo
    Corvatta, Laura
    Petrucci, Maria Teresa
    Fazio, Francesca
    CANCERS, 2023, 15 (11)
  • [8] Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients
    Salaun, Helene
    de Koning, Leanne
    Saint-Ghislain, Mathilde
    Servois, Vincent
    Ramtohul, Toulsie
    Garcia, Agathe
    Matet, Alexandre
    Cassoux, Nathalie
    Mariani, Pascale
    Piperno-Neumann, Sophie
    Rodrigues, Manuel
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [9] Clinical outcome of primary CNS lymphoma comparing the setting of "real-life" with a clinical trial: A single centre experience of 95 patients
    Zeremski, V
    Fischer, T.
    Schalk, E.
    Oncology Research and Treatment, 2015, 38 : 211 - 212
  • [10] Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study
    Nachbaur, David
    Angelova, Olga
    Orth-Hoeller, Dorothea
    Ditlbacher, Adelheid
    Lackner, Michaela
    Auberger, Jutta
    Lass-Floerl, Cornelia
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (03) : 258 - 264
12345